Auffargis, France

Ann-Marie Liberatore


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ann-Marie Liberatore: Innovator in Medicinal Chemistry

Introduction

Ann-Marie Liberatore is a distinguished inventor based in Auffargis, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic applications. Her innovative work focuses on derivatives of heterocycles, which have shown promising pharmacological properties.

Latest Patents

Ann-Marie holds a patent for "Derivatives of heterocycles with 5 members, their preparation and their use as medicaments." This patent includes thiazole, oxazole, imidazole, isoxazole, and isoxazoline compounds that are designed to treat neurodegenerative disorders or pain. The compounds exhibit advantageous pharmacological properties, making them valuable in therapeutic settings.

Career Highlights

Throughout her career, Ann-Marie has demonstrated a commitment to advancing medicinal chemistry. Her work has led to the development of innovative compounds that address critical health issues. She is currently associated with the Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS), where she continues to contribute to scientific research and development.

Collaborations

Ann-Marie has collaborated with notable colleagues, including Pierre-Etienne Chabrier De Lassauniere and Jermiah Harnett. These collaborations have further enriched her research and expanded the impact of her work in the field.

Conclusion

Ann-Marie Liberatore is a pioneering inventor whose work in medicinal chemistry has the potential to transform therapeutic approaches for neurodegenerative disorders and pain management. Her innovative spirit and dedication to research continue to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…